Interference by leptin with Helicobacter pylori lipopolysaccharide-induced cytosolic phospholipase A2 activation in gastric mucosal cells

Journal of Physiology and Pharmacology

Volumn 58, Issue 1, 2007, Pages 117-130

  Slomiany, B L ^a,b   Slomiany, A ^a,b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

cPLA2 activation; ERK; H. pylori; Leptin; Mucin synthesis; PAF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARACHIDONIC ACID; BACTERIUM LIPOPOLYSACCHARIDE; GINKGOLIDE A; METHYL ARACHIDONOYL FLUOROPHOSPHONATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; RECOMBINANT LEPTIN; STOMACH MUCIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG; WORTMANNIN; ANDROSTANE DERIVATIVE; ARACHIDONIC ACID DERIVATIVE; ENZYME INHIBITOR; FIBRINOGEN RECEPTOR; FLAVONOID; G PROTEIN COUPLED RECEPTOR; LACTONE; LEPTIN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, HELICOBACTER PYLORI; METHYL ARACHIDONYLFLUOROPHOSPHONATE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A; PHOSPHONIC ACID DERIVATIVE; PROTEIN KINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; HELICOBACTER PYLORI; MUCOSA CELL; NONHUMAN; PROTEIN SYNTHESIS; RAT; STOMACH MUCOSA; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; APOPTOSIS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GASTRIC MUCIN; GASTRIC MUCOSA; LACTONES; LEPTIN; LIPOPOLYSACCHARIDES; PHOSPHOLIPASES A; PHOSPHONIC ACIDS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 34248163391     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-S128.
2. Stolte M, Edit S. (1996) Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996; 31(Suppl 214): 13-16.
3. Piotrowski J. Lipopolysaccharide a virulence factor of Helicobacter pylori. J Physiol Pharmacol 1998; 49: 3-24.
4. de Boer WA. Helicobacter pylori infection: focus on a "search-and-treat" strategy for ulcer disease. Scand J Gastroenterol 2000; 35 (Suppl. 232): 4-9.
5. Piotrowski J, Piotrowski E, Skrodzka, et al. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1997; 32: 203-211.
6. Fu S, Ramanujan KS, Wong A, et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase-2 in Helicobacter pylori gastritis. Gastroenterology 1999; 116:1319-1329.
7. Slomiany BL, Slomiany A. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by peroxisome proliferator-activated receptor γ activation. Inflammopharmacol 2001; 8: 371-382.
8. Gupta RA, Polk DB, Krislina U, et al. Activation of peroxisome proliferator-activated receptor γ suppresses nuclear factor κB-mediated apoptosis induced by Helicobacter pylori in gastric epithelial cells. J Biol Chem 2001; 276: 31059-31066.
9. Slomiany BL, Slomiany A. Role of ERK and p38 mitogen-activated protein kinase cascades in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. IUBMB Life 2001; 51: 315-320.
10. Liau YH, Lopez RA, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of sulfated gastric mucin. Biochem Biophys Res Commun 1992; 113: 455-464.
11. Slomiany BL, Piotrowski J, Slomiany A, et al. Enhancement in the protective qualities of gastric mucus with combination therapy of ebrotidine and amoxicillin for H. pylori eradication. Gen Pharmacol 1998; 31: 227-231.
12. 2. Biochim Biophys Acta 2000; 1488: 124-138.
13. 2 activation and lipid generation in lipopolysaccharide-stimulated macrophages. J Biol Chem 2005; 280: 38969-38975.
14. 1 macrophages using GFP/REP constructs. Biochim Biophys Acta 2005; 1735:119-129.
15. +2- dependent death. J Biol Chem 2006; 281: 6106-6116.
16. Shukla SD. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J 1992; 6: 2296-2302.
17. Kravchenko VV, Pan Z, Han J, et al. Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway. J Biol Chem 1995; 270: 14928-14934.
18. 2 in allergic responses and parturition. Nature 1997; 390: 618-622.
19. 2 as defined by gene knockout. Biochim Biophys Acta 2000; 1488: 139-148.
20. Kim GS, Hong JS, Kim SW, et al. Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem 2003; 278: 21920-21929.
21. Hill RA, Margetic S, Pegg GC, Gazzola C Leptin: its pharmacokinetics and tissue distribution. Int J Obes 1998; 22: 765-770.
22. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65.
23. Faggioni, R., Feingold, K.R., and Grunfeld, C. Leptin regulation of the immune responses and immunodeficiency of malnutrition. FASEB J 2001; 15: 2565-2571.
24. Konturek PC, Brzozowski T, Sulekova Z, et al. Enhanced expression of leptin following acute gastric injury in rat. J Physiol Pharmacol 1999; 50: 587-595.
25. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999; 189: 207-212.
26. Slomiany BL, Slomiany A. Endothelin-1-dependent leptin induction in gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 2005; 336: 1106-1111.
27. Breidert M, Miehlke S, Glasgow A, et al. Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1999; 34: 954-961.
28. Azuma T, Suto H, Ito Y, et. al. Gastric leptin and Helicobacter pylori infection. Gut 2001; 49: 324-329.
29. Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol 2005; 11: 695-699.
30. 2 activation in Helicobacter pylori lipopolysaccharide-induced interference with gastric mucin synthesis. IUBMB Life 2006; 58, 217-223.
31. Slomiany BL, Slomiany A. Up-regulation in endothelin-1 by Helicobacter pylori lipopolysaccharide interferes with gastric mucin synthesis via epidermal growth factor receptor transactivation. Scand J Gastroenterol 2005; 40: 921-928.
32. 2 in prostaglandin-mediated action of sucralfate. Gen Pharmacol 1994; 25: 261-266.
33. Slomiany BL, Slomiany A. Role of epidermal growth factor receptor transactivation in PPARγdependent suppression of Helicobacter pylori interference with gastric mucin synthesis. Inflammopharmacol 2004; 12: 177-188.
34. Slomiany BL, Slomiany A. Platelet-activating factor mediates Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis. IUBMB Life 2004; 56: 41-46.
35. Sobhani I, Bado A, Vissuzaine C, et al. Leptin secretion and leptin receptor in the human stomach. Gut 2000; 47: 178-183.
36. 2 is phosphorylated and activated by MAP kinase. Cell 1993; 72: 269-278.
37. Shimabukuru M, Wang MY, Zhou YT, et al. Protection against lipoapoptosis of β cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998; 95: 9558-9561.
38. Rouet-Benzineb P, Aparicio T, Guilmeau S, et al. Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT29 cells via NF-κ signaling. J Biol Chem 2004; 279: 16495-16502.
39. Hayakawa M, Ishida N, Takeuchi K, et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993; 268: 11290-11295.
40. Dong M, Johnson M, Rezaie A, et al. Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis. Clin Cancer Res 2005; 11: 2265-2271.
41. Slomiany BL, Slomiany A. Role of leptin in modulation of Porphyromonas gingivalis lipopolysaccharide-induced up-regulation of endothelin-1 in salivary gland acinar cells. IUBMB Life 2005; 57: 591-595.
42. Suzuki S, Serizawa A, Sakaguchi T, et al. The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. Transplantation 2000; 69: 2267-2273.
43. Leung SW, Man GS, Man RY. Platelet-activating factor enhanced the pressor response of endothelin-1. J Cardiovasc Pharmacol 2002; 40: 528-532.
44. Slomiany BL, Slomiany A. Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 2003; 306: 261-266.